RxDoctor Payments Data

Manohar Vajja, MD

Internal Medicine · Dallas, TXNPI 1306048277

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 10th percentile of 7,675 internal medicine providers in Texas.

See all internal medicine providers in Texas

Medicare billing

Part B allowed, 2024
$451,601
Medicare patients
566
Services billed
11,150

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium36$602
Memantine Hcl20$549
Levetiracetam13$445
ValacyclovirValacyclovir Hcl12$402
Mirtazapine12$326
Potassium Chloride21$303
EnuloseLactulose12$282
Donepezil Hcl21$276
Metoprolol Succinate18$253
Oxybutynin Chloride ErOxybutynin Chloride11$244
Famotidine16$233
Simvastatin11$153
Levothyroxine Sodium20$141
Amlodipine Besylate15$120
Lisinopril11$116

Paid to pharmacies, not to this prescriber.

Other internal medicine in Dallas

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →